ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 81.9 | 97.5 | 23.4 |
| Other income | 1.5 | 0.8 | 7.5 |
| Total income | 83.4 | 98.3 | 30.9 |
| Profit before exceptional items & tax | 7.8 | -7.6 | 10.1 |
| Profit before tax | 7.8 | -7.6 | 10.1 |
| Net profit | 3.8 | -12.4 | 4.9 |
| Operating margin | 9.4% | -7.7% | 32.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -22.40% |
|---|---|
| Revenue, year on year | +250.00% |
| Operating profit, year on year | +142.30% |
| Operating profit, quarter on quarter | +175.00% |
BSE results filing, NSE: FISCHER. Figures extracted from the filing.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹25.13
- Market cap
- ₹1,741 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 58.4×Sector 35.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Board Meeting Date
Fischer Medical Ventures has intimated a board meeting on 14 November 2026 to consider unaudited Q2 results. The trading window stays closed until 48 hours after results.
Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.